Lars Baumann

This inventor holds 1 USPTO granted patent. Top assignees: Bayer Aktiengesellschaft, Bayer Pharma Aktiengesellschaft. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lars Baumann. Retrieved from https://idiyas.com/inventor/lars-baumann-18sd6g9n

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 14.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lars Baumann: Innovator in Pharmaceutical Research

Introduction

Lars Baumann is a notable inventor recognized for his contributions to pharmaceutical research. He has developed innovative solutions that have the potential to impact various medical fields. His work is characterized by a commitment to advancing healthcare through scientific discovery.

Latest Patents

Lars Baumann holds 1 patent, which is titled "MASP Inhibitory Compounds and Uses Thereof." This patent reflects his expertise in developing compounds that can inhibit specific biological processes, showcasing his innovative approach to addressing medical challenges.

Career Highlights

Throughout his career, Lars has worked with prominent companies in the pharmaceutical industry, including Bayer Aktiengesellschaft and Bayer Pharma Aktiengesellschaft. His experience in these organizations has allowed him to contribute significantly to research and development efforts in the field.

Collaborations

Lars has collaborated with esteemed colleagues such as Donald Bierer and Ingo Flamme. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research endeavors.

Conclusion

Lars Baumann is a distinguished inventor whose work in pharmaceutical research continues to influence the industry. His innovative patent and collaborations with leading professionals highlight his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…